CM-579 inhibits the enzymes that add methyl groups to histone proteins, altering chromatin structure and gene expression. It targets DNA methyltransferase, DNMT1, DNMT3A, DNMT3B, and G9a.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.